UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Personal financial planning offers numerous benefits, including better money management and goal achievement. Start planning for your future today.
20,770 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Anthropic’s latest coding assistant is reshaping how enterprises buy software, potentially ending seat-based licenses...
Strive raises the dividend on SATA preferred stock to 12.75% and deploys $50 million into Strategy's STRC, while incr...
Meta unveils its MTIA 300 AI inference chip, signaling a move to in-house AI deployment that could alter ROI dynamics...
A growing cohort of retirees is buying into the Taiwan-centric ETF EWT to capture gains from Taiwan’s chipmakers. The...
private listings escalating. here’s a timely look at how brokerages and portals could resolve mounting tensions while...
A discount retailer is stacking double-digit comps on top of double-digit comps. This article breaks down what that m...
Two popular small-cap growth ETFs—ISCG and VBK—aim to capture the fast-growing corner of the U.S. market. This guide ...
Geopolitics can push oil to $100 a barrel, but certain pipeline stocks thrive on throughput rather than price. Learn ...
Oracle is racing to reinvent itself as an AI-enabled cloud platform, funding AI infrastructure with debt while juggli...
Bitcoin pulled back toward $68,000 as new geopolitical threats stoked risk-off sentiment. Traders weigh whether the d...
Grab lands its first expansion outside Southeast Asia by acquiring Foodpanda Taiwan for $600 million, targeting a lat...